APA

United States, . (1998). Off-label drug use and FDA review of supplemental drug applications: hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996. Washington: U.S. Government Printing Office.

Chicago

United States, . 1998. Off-label drug use and FDA review of supplemental drug applications: hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996. Washington: U.S. Government Printing Office.

Harvard

United States, . (1998). Off-label drug use and FDA review of supplemental drug applications: hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996. Washington: U.S. Government Printing Office.

MLA

United States, . Off-label drug use and FDA review of supplemental drug applications: hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996. Washington: U.S. Government Printing Office. 1998.